Location of Airway Inflammation in Asthma and the Relationship to Orcadian Change in Lung Function

References

• Ballard R D, Irvin C G, Martin R J, et al. Influence of sleep on lung volumes in asthmatic patients and normal subjects. J Appl Physiol 1990; 68: 2034–41
   PubMed Web of Science ®Google Scholar
• Ballard R D, Saathoff M C, Patel D K, et al. Effect of sleep on nocturnal broncho-constriction and ventilatory patterns in asthmatics. J Appl Physiol 1989; 67: 243–49
   PubMedGoogle Scholar
• Barnes P, Fitzgerald G, Brown M, et al. Nocturnal asthma and changes in circulating epinephrine, histamine and Cortisol. N Engl J Med 1980; 303: 263–67
   PubMed Web of Science ®Google Scholar
• Beam W R, Weiner D E, Martin R J. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146: 1524–30
   PubMedGoogle Scholar
• Coe C I, Barnes P J. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest 1986; 90: 485–88
   PubMed Web of Science ®Google Scholar
• ĎAlonzo G E, Smolensky M H, Feldman S, et al. Twenty-four hour lung function in adult patients with asthma. Am Rev Respir Dis 1990; 142: 84–90
   PubMedGoogle Scholar
• Dethlefsen U, Repgas R. Ein neues therapieprinzip bei nachtlichen asthma. Klin Med 1985; 80: 44–47
   Google Scholar
• deVries K, Goei J T, Booy-Noored H, et al. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy 1962; 20: 93–101
   Google Scholar
• Fitzpatrick M F, Mackay T, Driver H, et al. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled β2 agonist. Br Med J 1990; 301: 1365–68
   PubMedGoogle Scholar
• Gervais P, Reinberg A, Gervais C, et al. Twenty-four-hour rhythm in the bronchial hyperreactivity to house dust in asthmatics. J Allergy Clin Immunol 1977; 59: 207–13
   PubMedGoogle Scholar
• Hetzel M R, Clark T JH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732–38
   PubMed Web of Science ®Google Scholar
• Jarjour N N, Calhoun W J, Busse W W. Enhanced metabolism of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992; 146: 905–11
   PubMed Web of Science ®Google Scholar
• Kellenbach J M, Webster T, Dowdeswell R, et al. Reflex heart rate control in asthma: evidence of parasympathetic overactivity. Chest 1985; 87: 644–48
   PubMedGoogle Scholar
• Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505–10
   PubMed Web of Science ®Google Scholar
• Martin R J. Nocturnal asthma: an overview. Nocturnal asthma: mechanisms and treatment, R J Martin. Futura, Mount Kisco, New York 1993; 71–115
   Google Scholar
• Martin R J, Cicutto L C, Ballard R D. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990; 141: 33–38
   PubMed Web of Science ®Google Scholar
• Martin R J, Cicutto L C, Ballard R D, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143: 351–57
   PubMed Web of Science ®Google Scholar
• Martin R J, Pak J, Irvin C G. The effect of lung volume maintenance during sleep in nocturnal asthma. J Appl Physiol 1993; 75: 1467–70
   PubMedGoogle Scholar
• Morrison J FJ, Pearson S B, Dean H G. Parasympathetic nervous system in nocturnal asthma. Br Med J 1988; 296: 1427–29
   PubMed Web of Science ®Google Scholar
• Pincus D J, Szefler S J, Ackerson L M, et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95: 1172–78
   PubMed Web of Science ®Google Scholar
• Postma D S, Koeter G H, Meurs H, et al. Slow release terbutaline in nocturnal bronchial obstruction: relation of terbutaline dosage and blood levels with circadian changes in peak flow values. Annu Rev Chronopharmacol 1984; 1: 101–4
   Google Scholar
• Reinberg A, Gervais P, Morin M, . Circadian rhythms in the threshold of bronchial response to acetylcholine in healthy and asthmatic subjects. Chronobiology, L E Scheving, et al. Igaku Shoin, Tokyo 1974; 174–77
   Google Scholar
• Reinberg A, Guillet P, Gervais P, et al. One month chronocorticotherapy (Dutimelan 8 15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration. Chronobiologia 1977; 4: 295–312
   PubMedGoogle Scholar
• Reinberg A E. Circadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1974; 1: 333–37
   PubMedGoogle Scholar
• Robertson C E, Rubinfeld A R, Bowej G. Deaths from asthma in Victoria: a 12-month study. Med J Australia 1990; 152: 511–17
   PubMed Web of Science ®Google Scholar
• Szefler S J, Ando R, Cicutto L C, et al. Plasma histamine, epinephrine, Cortisol, and leukocyte sβ-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49: 59–68
   PubMed Web of Science ®Google Scholar
• Turki J, Pak J, Green S A, et al. Genetic polymorphisms of the β-2 adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95: 1635–41
   PubMed Web of Science ®Google Scholar
• Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85(suppl IB)6–8
   PubMedGoogle Scholar
• Wagner E M, Liu M C, Weinmann G G, et al. Peripheral lung resistance in normals and asthmatic subjects. Am Rev Respir Dis 1990; 141: 584–88
   PubMedGoogle Scholar
• Wenzel S E, Trudeau J B, Kaminsky D A, et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152: 897–905
   PubMed Web of Science ®Google Scholar